Physician profile
William B Salt
NPI 1568456804
$87,119.74
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65K · 2020: $13K · 2021: $7,453 · 2023: $1,600 · 2024: $31.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,600 · Food and Beverage: $31.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,600.00 |
| Food and Beverage | $31.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36,142.89 | 2019-2020 | |
| Qol Medical, LLC | $34,161.76 | 2019-2024 | Sucraid |
| Concordia Pharmaceuticals INC. | $8,468.20 | 2019 | |
| Romark Laboratories, Lc | $3,709.22 | 2019-2020 | |
| Capsovision, INC. | $1,600.00 | 2023 | Capsocam Plus |
| Parapro, LLC | $1,357.57 | 2019 | |
| Alfasigma USA, INC. | $1,250.00 | 2020 | |
| Allergan, INC. | $239.31 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $95.84 | 2019-2020 | |
| Redhill Biopharma INC. | $89.63 | 2020 | |
| Vivus LLC | $5.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Salt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.